Targeting notch signaling as a safe and effective treatment for autoimmune and lymphoproliferative diseases.

被引：0
|
作者：
Teachey, David T. [1 ]
Seif, Alix [1 ]
Hall, Junior [1 ]
Ryan, Theresa [1 ]
Reid, Gregor [1 ]
Chang, Yueh [1 ]
Brown, Valerie [1 ]
Grupp, Stephan A. [1 ]
机构：
[1] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
647
引用
收藏
页码：195A / 195A
页数：1
相关论文
共 50 条
  • [1] Targeting Notch signaling in autoimmune and lymphoproliferative disease
    Teachey, David T.
    Seif, Alix E.
    Brown, Valerie I.
    Bruno, Marlo
    Bunte, Ralph M.
    Chang, Yueh J.
    Choi, John K.
    Fish, Jonathan D.
    Hall, Junior
    Reid, Gregor S.
    Ryan, Theresa
    Sheen, Cecilia
    Zweidler-McKay, Patrick
    Grupp, Stephan A.
    BLOOD, 2008, 111 (02) : 705 - 714
  • [2] Notch inhibitors are a novel, safe, and effective treatment for autoimmune lymphoproliferative syndrome (ALPS)
    Teachey, David T.
    Seif, Alix
    Hall, Junior
    Ryan, Theresa
    Sheen, Cecelia
    Reid, Gregor
    Cheng, Yueh
    Brown, Valerie I.
    Grupp, Stephan A.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 633 - 634
  • [3] Targeting the Notch signaling pathway in autoimmune diseases
    Ma, Daoxin
    Zhu, Yuanchao
    Ji, Chunyan
    Hou, Ming
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (05) : 553 - 565
  • [4] Targeting Treg signaling for the treatment of autoimmune diseases
    Spence, Allyson
    Klementowiczl, Joanna E.
    Bluestone, Jeffrey A.
    Tang, Qizhi
    CURRENT OPINION IN IMMUNOLOGY, 2015, 37 : 11 - 20
  • [5] Human foamy virus in systemic autoimmune and B lymphoproliferative diseases.
    Yvon, A
    Calvez, V
    Amoura, Z
    Gatel, A
    Dupin, N
    DeGennes, C
    Agut, H
    Godeau, P
    Piette, JC
    Cacoub, P
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 727 - 727
  • [6] Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis
    Strassburg, C. P.
    Manns, M. P.
    INTERNIST, 2011, 52 (12): : 1394 - +
  • [7] Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases
    Christopoulos, Panagiotis F.
    Gjolberg, Torleif T.
    Kruger, Stig
    Haraldsen, Guttorm
    Andersen, Jan Terje
    Sundlisaeter, Eirik
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Xcellerate™ therapy:: A novel therapeutic strategy for the treatment of autoimmune diseases.
    Berenson, RJ
    Long, SA
    Kalamasz, D
    Ferrand, C
    Richards, M
    Khalili, J
    Frohlich, M
    Bonyhadi, ML
    BLOOD, 2003, 102 (11) : 239A - 239A
  • [9] Venous thromboembolism treatment duration in autoimmune diseases. Research trends
    Ruiz-Sada, Pablo
    Palacios-Garcia, Lara
    Sada-Sainz, Julia
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 95 : 100 - 101
  • [10] Sirolimus is Effective in Treatment of Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)
    Deripapa, E. V.
    Smirnova, I. N.
    Varlamova, T. A.
    Bobrynina, V. O.
    Shvets, O. A.
    Baidildina, D. D.
    Fisiun, I. V.
    Kalinina, I. I.
    Maschan, M. A.
    Shcherbina, A.
    Maschan, A. A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S302 - S302
12345